Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Not Yet Recruiting

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

NCT07302776

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +21 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Not Yet Recruiting

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

NCT07529951

Conditions: Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts

NCT07498205

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients

NCT07489755

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias

NCT07447817

Conditions: Anemia, Blood Platelet Disorders, Bone Marrow Diseases, +9 more
Locations: The University of Kansas Cancer Center-Westwood Westwood, Kansas, United States

Icahn School of Medicine at Mount Sinai New York, United States

Wake Forest Baptist Health Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Not Yet Recruiting

Gecacitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis

NCT07471503

Conditions: Bone Marrow Diseases, HSCT, Hematologic Diseases, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis

NCT07440654

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Bomedemstat (IMG-7289) in Combination With Momelotinib in Patients With Myelofibrosis

NCT07424950

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients

NCT07413263

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera

NCT07341048

Conditions: Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +8 more
Locations: Department of Sports Medicine and Physical Activity. Pulmonary Function Testing. Croix Rousse Hospital. Lyon, France

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions